Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025

世界の次世代シーケンシング(NGS)市場:製品別(NOVASEQ、NEXTSEQ、SEQUEL、NANOPORE)、消耗品別、バイオインフォマティクス別、サービス別(EXOME、RNA、DENOVO)、技術別(ION、SMRT)、 用途別(診断、がん)、エンドユーザー別、地域別

◆タイトル:Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025
◆商品コード:BT 2697
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年12月23日
◆ページ数:228
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は、次世代シーケンシング(NGS)の世界市場規模が2019年78億ドルから2025年244億ドルまで年平均20.9%成長すると予測しています。本書は、世界の次世代シーケンシング(NGS)市場について調査・分析し、市場概要、製品&サービス別(事前シーケンス製品&サービス/サンプル準備、NGS消耗品、NGSプラットフォーム、NGSプラットフォーム向けサービス、シーケンスサービス、バイオインフォマティクス)分析、技術別(合成によるシーケンス、ION半導体シーケンス、単一分子リアルタイムシーケンス、ナノポアシーケンス、その他)分析、用途別(診断、薬物発見、農業および動物研究、その他)分析、エンドユーザー別(学術研究所&研究センター、製薬&バイオテクノロジー、病院&クリニック、その他)分析、地域別分析、競合環境、企業概要などを掲載しております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の次世代シーケンシング(NGS)市場:製品&サービス別(事前シーケンス製品&サービス/サンプル準備、NGS消耗品、NGSプラットフォーム、NGSプラットフォーム向けサービス、シーケンスサービス、バイオインフォマティクス)
・世界の次世代シーケンシング(NGS)市場:技術別(合成によるシーケンス、ION半導体シーケンス、単一分子リアルタイムシーケンス、ナノポアシーケンス、その他)
・世界の次世代シーケンシング(NGS)市場:用途別(診断、薬物発見、農業および動物研究、その他)
・世界の次世代シーケンシング(NGS)市場:エンドユーザー別(学術研究所&研究センター、製薬&バイオテクノロジー、病院&クリニック、その他)
・世界の次世代シーケンシング(NGS)市場:地域別
・競合環境
・企業概要
・付録

“The global NGS market is projected to grow at a CAGR of 20.9% during the forecast period.”
The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%. The growth of this market is largely driven by advancements in and the declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. The NGS market is segmented based on application, technology, product & service, end user, and region.

“The SBS segment accounted for the largest share of the NGS market in 2018.”
On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. In 2018, the SBS segment accounted for the largest share of the NGS market. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of SBS-based NGS platforms (including the HiSeq MiSeq series and NextSeq).

“The diagnostics application segment accounted for the largest share of the NGS market in 2018.”
Based on applications, the NGS market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications, which include marine research and research in biofuels, forensics, metagenomic studies, and evolutionary studies. Of all these application segments, diagnostics accounted for the largest share of the NGS market in 2018. The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT.

“North America accounted for the largest share of the NGS market in 2018.”
North America accounted for the largest share of the NGS market in 2018, followed by Europe. This can primarily be attributed to factors such as the increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 (30%), Tier 2 (32%), and Tier 3 (38%)
• By Designation: C-level (26%), Director-level (30%), and Others (44%)
• By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

Some of the prominent players in the NGS market include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. Ltd. (India), GENEWIZ (US), Takara Bio Inc. (Japan), Eurofins Scientific (Luxembourg), 10x Genomics (US), F. Hoffmann- La Roche Ltd (Switzerland), Becton Dickinson and Company (US), Danaher (US), Lexogen GmbH (Austria), Tecan Trading AG (Switzerland), Zymo Research (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), and QIAGEN (Netherlands).

Research Coverage
This report studies the NGS market based on product & service, technology, application, end user, and region. It studies major factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to four major regions and their respective major countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the NGS market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 24)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Application-Based Market Estimation
2.3 Market Breakdown & Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 33)
4 Premium Insights (Page No. – 38)
4.1 Next-Generation Sequencing Market Overview
4.2 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)
4.3 Next-Generation Sequencing Market Share, By Technology, 2019 vs 2025
4.4 Next-Generation Sequencing Market, By Application, 2019 vs 2025 (USD Million)
4.5 Next-Generation Sequencing Market, By End User, 2019 vs 2025 (USD Million)
4.6 Next-Generation Sequencing Market: Geographical Snapshot
5 Market Overview (Page No. – 42)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advancements in NGS Platforms
5.2.1.1.1 ISEQ
5.2.1.1.2 ION Genestudio S5
5.2.1.2 Declining Costs
5.2.1.3 Improving Regulatory and Reimbursement Scenario for NGS-Based Diagnostic Tests
5.2.2 Restraints
5.2.2.1 End-User Budget Constraints in Developing Nations
5.2.3 Opportunities
5.2.3.1 Government & Private Support for Large-Scale Sequencing
5.2.3.2 Application of NGS in Precision Medicine and Molecular Diagnostics
5.2.3.3 NGS Data Analysis Using Big Data
5.2.4 Challenges
5.2.4.1 Interpretation of Complex Data From NGS Platforms
5.2.4.2 Ethical Issues
5.2.5 Industry Trends
5.2.5.1 Development of Portable Sequencing Technologies
5.2.5.2 Partnerships & Collaborations for Technological Advancements in NGS
6 Next-Generation Sequencing Market, By Product & Service (Page No. – 50)
6.1 Introduction
6.2 Presequencing Products & Services/Sample Preparation
6.2.1 Increasing Automation in Sample Preparation to Drive Market Growth
6.2.1.1 Library Preparation & Target Enrichment
6.2.1.2 Quality Control
6.3 NGS Consumables
6.3.1 Growing Number of Sequencing Procedures to Propel the Demand for NGS Consumables
6.4 NGS Platforms
6.4.1 Significant Transformation Experienced in the Market Due to Entry of New NGS Platform Providers
6.4.2 Illumina
6.4.2.1 Hiseq Systems
6.4.2.2 Hiseq X Ten & Hiseq X Five Systems
6.4.2.3 Miseq Systems
6.4.2.4 Nextseq Systems
6.4.2.5 Miniseq Systems
6.4.2.6 Novaseq Systems
6.4.2.7 ISEQ 100 Systems
6.4.3 Thermo Fisher Scientific
6.4.3.1 ION PGM Systems
6.4.3.2 ION Proton
6.4.3.3 ION Genestudio S5
6.4.4 Oxford Nanopore Technologies
6.4.5 Pacific Biosciences
6.4.5.1 Pacbio RS Ii
6.4.5.2 Sequel Systems
6.4.6 Other NGS Platforms
6.5 Services for NGS Platforms
6.5.1 Increasing Installation of NGS Platforms to Support Market Growth
6.6 Sequencing Services
6.6.1 Exome & Targeted Resequencing and Custom Panels
6.6.1.1 Development of Technologically Advanced NGS Products & Services to Propel Market Growth
6.6.2 Rna-Seq
6.6.2.1 Launch of Advanced Rna Products & Services to Drive Market Growth
6.6.3 Whole-Genome Sequencing & De Novo Sequencing
6.6.3.1 Reducing Whole-Genome Sequencing Costs to Propel the Growth of This Segment
6.6.4 Other Sequencing Services
6.7 Bioinformatics
6.7.1 NGS Data Analysis Software & Workbenches
6.7.1.1 Development of Advanced Bioinformatics Solutions to Drive Growth in This Segment
6.7.2 NGS Data Analysis Services
6.7.2.1 Availability of Data Analysis Services is the Major Factor Supporting the Growth of This Market.
6.7.3 NGS Storage, Management, and Cloud Computing Solutions
6.7.3.1 Launch of Cloud-Based Solutions to Drive the Market
7 Next-Generation Sequencing Market, By Technology (Page No. – 77)
7.1 Introduction
7.2 Sequencing By Synthesis
7.2.1 Sbs Technology Enables the Highest Production of Base Pairs in A Short Period of Time
7.3 ION Semiconductor Sequencing
7.3.1 ION Semiconductor Sequencing Platforms Possess High-Throughput Capabilities
7.4 Single-Molecule Real-Time Sequencing
7.4.1 Smrt Sequencing Produces Results in A Short Time and at Lower Costs
7.5 Nanopore Sequencing
7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct Rna Sequencing Capabilities
7.6 Other Sequencing Technologies
8 Next-Generation Sequencing Market, By Application (Page No. – 84)
8.1 Introduction
8.2 Diagnostics
8.2.1 Cancer Diagnostics
8.2.1.1 Growing Number of New Cancer Cases to Propel Market Growth
8.2.2 Infectious Disease Diagnostics
8.2.2.1 Lack of Awareness About NGS-Based Diagnosis for Infectious Diseases to Hamper Market Growth
8.2.3 Reproductive Health Diagnostics
8.2.3.1 Increasing Awareness About the Benefits of Nipt to Propel Market Growth
8.2.4 Other Diagnostic Applications
8.3 Drug Discovery
8.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery to Support Market Growth
8.4 Agricultural & Animal Research
8.4.1 Growing Funding & Support for Animal & Plant Genomics Research to Drive Market Growth
8.5 Other Applications
9 Next-Generation Sequencing Market, By End User (Page No. – 95)
9.1 Introduction
9.2 Academic Institutes & Research Centers
9.2.1 Development of Cost-Effective NGS Products & Services for Researchers to Propel Market Growth
9.3 Pharmaceutical & Biotechnology Companies
9.3.1 Growing Agreements & Collaborations Between Next-Generation Sequencing Market Players and Pharma Biotech Firms to Fuel Market Growth
9.4 Hospitals & Clinics
9.4.1 Development of Advanced NGS-Based Diagnostic Solutions to Enhance the Adoption of NGS in Hospitals & Clinics
9.5 Other End Users
10 Next-Generation Sequencing Market, By Region (Page No. – 101)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Growing R&D Activities in the US to Drive Market Growth
10.2.2 Canada
10.2.2.1 Increasing Government Initiatives in Genomics Research Will Boost the Adoption of NGS
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Dominates the European Next-Generation Sequencing Market
10.3.2 France
10.3.2.1 Government Initiatives to Support Genomics Research—A Major Factor Driving Market Growth in France
10.3.3 UK
10.3.3.1 Favorable Funding Scenario for Genomics Research in the Country to Support the Adoption of NGS
10.3.4 Spain
10.3.4.1 Increasing Number of Conferences Focusing on NGS to Support Market Growth in Spain
10.3.5 Italy
10.3.5.1 Favorable Funding Scenario to Drive the Next-Generation Sequencing Market in Italy
10.3.6 Netherlands
10.3.6.1 Increasing Focus of Market Players on Developing NGS Technologies to Support Market Growth
10.3.7 RoE
10.4 Asia Pacific
10.4.1 China
10.4.1.1 China to Register the Highest Growth in the APAC Next-Generation Sequencing Market
10.4.2 Japan
10.4.2.1 High Incidence of Genetic Disorders in the Country has Resulted in the Increased Adoption of NGS
10.4.3 Australia
10.4.3.1 Increasing Public and Private Initiatives to Support the Adoption of NGS Technologies in Australia
10.4.4 India
10.4.4.1 Growing Prevalence of Target Diseases in India to Support Market Growth
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.1.1 High Prevalence of HIV in Brazil to Drive the Demand for NGS
10.5.2 Mexico
10.5.2.1 Economic Growth in Mexico to Support the Growth of the Next-Generation Sequencing Market
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Lack of Infrastructure for Genomics Research to Hamper the Growth of the Next-Generation Sequencing Market in the Mea
11 Competitive Landscape (Page No. – 144)
11.1 Introduction
11.2 Competitive Leadership Mapping (Overall Market)
11.2.1 Terminology/Nomenclature
11.2.1.1 Visionary Leaders
11.2.1.2 Innovators
11.2.1.3 Dynamic Differentiators
11.2.1.4 Emerging Companies
11.3 Competitive Scenario (2016–2019)
11.4 Next-Generation Sequencing Market Ranking: Top Three Market Players (2018)
12 Company Profiles (Page No. – 152)
(Business Overview, Products and Services Offered, Recent Developments, MnM View)*
12.1 Illumina, Inc.
12.2 Thermo Fisher Scientific, Inc.
12.3 BGI Group
12.4 Perkinelmer
12.5 Agilent Technologies, Inc.
12.6 Qiagen N.V.
12.7 F. Hoffmann-La Roche AG
12.8 Genewiz (A Part of Brooks Automation)
12.9 Eurofins Scientific
12.10 Psomagen, Inc. (Formerly Known as Macrogen)
12.11 Oxford Nanopore Technologies
12.12 10x Genomics
12.13 Takara Bio
12.14 Zymo Research
12.15 Nugen Technologies (A Part of Tecan Trading AG)
12.16 Other Companies
12.16.1 Hamilton Company
12.16.2 Beckman Coulter (A Subsidiary of Danaher)
12.16.3 Becton, Dickinson and Company
12.16.4 Genotypic Technology
12.16.5 Lucigen Corporation
*Business Overview, Products and Services Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 218)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables (123 Tables)
Table 1 Global Sequencing Initiatives
Table 2 Partnerships & Collaborations, 2017–2019
Table 3 Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 4 Presequencing Products & Services Market, By Region, 2017–2025 (USD Million)
Table 5 Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 6 Library Preparation & Target Enrichment Market, By Region, 2017–2025 (USD Million)
Table 7 Quality Control Market, By Region, 2017–2025 (USD Million)
Table 8 NGS Consumables Market, By Region, 2017–2025 (USD Million)
Table 9 NGS Platforms Market, By Type, 2017–2025 (USD Million)
Table 10 NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 11 Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 12 Illumina NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 13 Hiseq Systems Market, By Region, 2017–2025 (USD Million)
Table 14 Hiseq X Ten & Hiseq X Five Market, By Region, 2017–2025 (USD Million)
Table 15 Miseq Systems Market, By Region, 2017–2025 (USD Million)
Table 16 Nextseq Systems Market, By Region, 2017–2025 (USD Million)
Table 17 Miniseq Systems Market, By Region, 2017–2025 (USD Million)
Table 18 Novaseq Systems Market, By Region, 2017–2025 (USD Million)
Table 19 ISEQ 100 Systems Market, By Region, 2017–2025 (USD Million)
Table 20 Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 21 Thermo Fisher Scientific NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 22 ION PGM Platforms Market, By Region, 2017–2025 (USD Million)
Table 23 ION Proton Systems Market, By Region, 2017–2025 (USD Million)
Table 24 ION Genestudio S5 Platforms Market, By Region, 2017–2025 (USD Million)
Table 25 Oxford Nanopore Technologies NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 26 Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 27 Pacific Biosciences NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 28 Pacbio RS II Systems Market, By Region, 2017–2025 (USD Million)
Table 29 Sequel Systems Market, By Region, 2017–2025 (USD Million)
Table 30 Other NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 31 Services for NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 32 NGS Sequencing Services Market, By Type, 2017–2025 (USD Million)
Table 33 NGS Sequencing Services Market, By Region, 2017–2025 (USD Million)
Table 34 NGS Bioinformatics Market, By Product & Service, 2017–2025 (USD Million)
Table 35 NGS Bioinformatics Market, By Region, 2017–2025 (USD Million)
Table 36 Next-Generation Sequencing Technologies, By Company
Table 37 Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 38 Sequencing By Synthesis Market, By Region, 2017–2025 (USD Million)
Table 39 ION Semiconductor Sequencing Market, By Region, 2017–2025 (USD Million)
Table 40 Single-Molecule Real-Time Sequencing Market, By Region, 2017–2025 (USD Million)
Table 41 Nanopore Sequencing Market, By Region, 2017–2025 (USD Million)
Table 42 Other Sequencing Technologies, By Region, 2017–2025 (USD Million)
Table 43 Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 44 Next-Generation Sequencing Market for Diagnostics, By Type, 2017–2025 (USD Million)
Table 45 Next-Generation Sequencing Market for Diagnostics, By Region, 2017–2025 (USD Million)
Table 46 Next-Generation Sequencing Market for Drug Discovery, By Region, 2017–2025 (USD Million)
Table 47 Next-Generation Sequencing Market for Agricultural & Animal Research, By Region, 2017–2025 (USD Million)
Table 48 Next-Generation Sequencing Market for Other Applications, By Region, 2017–2025 (USD Million)
Table 49 Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 50 Next-Generation Sequencing Market for Academic Institutes & Research Centers, By Region, 2017–2025 (USD Million)
Table 51 Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2025 (USD Million)
Table 52 Next-Generation Sequencing Market for Hospitals & Clinics, By Region, 2017–2025 (USD Million)
Table 53 Next-Generation Sequencing Market for Other End Users, By Region, 2017–2025 (USD Million)
Table 54 Next-Generation Sequencing Market, By Region, 2017–2025 (USD Million)
Table 55 North America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 56 North America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 57 North America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 58 North America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 59 North America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 60 North America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 61 North America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 62 North America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 63 North America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 64 North America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 65 US: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 66 Canada: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 67 Europe: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 68 Europe: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 69 Europe: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 70 Europe: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 71 Europe: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 72 Europe: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 73 Europe: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 74 Europe: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 75 Europe: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 76 Europe: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 77 Germany: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 78 France: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 79 UK: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 80 Spain: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 81 Italy: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 82 Netherlands: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 83 RoE: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 84 Asia Pacific: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 85 Asia Pacific: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 86 Asia Pacific: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 87 Asia Pacific: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 88 Asia Pacific: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 89 Asia Pacific: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 90 Asia Pacific: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 91 Asia Pacific: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 92 Asia Pacific: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 93 Asia Pacific: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 94 China: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 95 Japan: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 96 Australia: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 97 India: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 98 RoAPAC: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 99 Latin America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 100 Latin America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 101 Latin America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 102 Latin America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 103 Latin America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 104 Latin America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 105 Latin America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 106 Latin America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 107 Latin America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 108 Latin America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 109 Brazil: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 110 Mexico: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 111 RoLA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 112 MEA: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 113 MEA: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 114 MEA: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 115 MEA: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 116 MEA: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 117 MEA: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 118 MEA: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 119 MEA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 120 MEA: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 121 New Product Launches
Table 122 Acquisitions
Table 123 Partnerships, Agreements, & Collaborations

List of Figures (41 Figures)
Figure 1 Next-Generation Sequencing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Next-Generation Sequencing Market: Product-Based Estimation
Figure 5 NGS Platforms Market: Product-Based Estimation
Figure 6 Next-Generation Sequencing Market: Application-Based Estimation
Figure 7 Next-Generation Sequencing Market: Data Triangulation
Figure 8 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)
Figure 9 Next-Generation Sequencing Market, By Technology, 2019 vs 2025 (USD Million)
Figure 10 Next-Generation Sequencing Market Share, By Application, 2019 vs 2025
Figure 11 Next-Generation Sequencing Market Share, By End User, 2019 vs 2025
Figure 12 Next-Generation Sequencing Market: Geographical Snapshot
Figure 13 Advancements and Declining Costs in NGS Platforms to Drive Market Growth
Figure 14 NGS Consumables to Dominate the Next-Generation Sequencing Market During the Forecast Period
Figure 15 Sequencing By Synthesis to Hold the Largest Share of the Market During the Forecast Period
Figure 16 Diagnostic Applications to Hold the Largest Share of the Next-Generation Sequencing Market in 2019
Figure 17 Academic Institutes & Research Centers to Dominate the Next-Generation Sequencing Market in 2019
Figure 18 China is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 19 Next-Generation Sequencing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Cost of Human Whole-Genome Sequencing, 2001–2019
Figure 21 Data Production During Human Whole-Genome Sequencing, 2001–2019
Figure 22 Funding for Cancer Research in the US (2018)
Figure 23 Number of Pubmed Research Publications on NGS-Based Drug Discovery, 2008–2017
Figure 24 North America: Next-Generation Sequencing Market Snapshot
Figure 25 Europe: Next-Generation Sequencing Market Snapshot
Figure 26 Asia Pacific: Next-Generation Sequencing Market Snapshot
Figure 27 Next-Generation Sequencing Market, Competitive Leadership Mapping, 2018
Figure 28 Next-Generation Sequencing Market, Competitive Leadership Mapping, 2018 (SMEs/Start-UPS)
Figure 29 Key Developments in the Next-Generation Sequencing Market, 2016–2019
Figure 30 Illumina Held the Leading Position in the Next-Generation Sequencing Market as of 2018
Figure 31 Illumina Held the Leading Position in the NGS Platforms Market as of 2018
Figure 32 Illumina: Company Snapshot (2018)
Figure 33 Thermo Fisher Scientific: Company Snapshot (2018)
Figure 34 Perkinelmer: Company Snapshot (2018)
Figure 35 Agilent Technologies: Company Snapshot (2018)
Figure 36 Qiagen N.V. : Company Snapshot (2018)
Figure 37 F. Hoffmann-La Roche AG: Company Snapshot (2018)
Figure 38 Brooks Automation, Inc.: Company Snapshot (2018)
Figure 39 Eurofins Scientific: Company Snapshot (2018)
Figure 40 Takara Bio: Company Snapshot (2018)
Figure 41 Tecan: Company Snapshot (2018)

★調査レポート[世界の次世代シーケンシング(NGS)市場:製品別(NOVASEQ、NEXTSEQ、SEQUEL、NANOPORE)、消耗品別、バイオインフォマティクス別、サービス別(EXOME、RNA、DENOVO)、技術別(ION、SMRT)、 用途別(診断、がん)、エンドユーザー別、地域別] ( Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025 / BT 2697) 販売に関する免責事項
[世界の次世代シーケンシング(NGS)市場:製品別(NOVASEQ、NEXTSEQ、SEQUEL、NANOPORE)、消耗品別、バイオインフォマティクス別、サービス別(EXOME、RNA、DENOVO)、技術別(ION、SMRT)、 用途別(診断、がん)、エンドユーザー別、地域別] ( Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025 / BT 2697) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆